Page 2 - Selective Targeting News Today

FEFKA alleges a plot as Malayalam director Najeem Koya is targeted in a controversial excise raid following drug-related concerns. FEFKA raises complaints against the Excise Intelligence Department, highlighting selective targeting and demands fair investigation and due process in the industry.

BOSTON, June 05, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | June 5, 2023

BOSTON, May 09, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T... | May 9, 2023

BOSTON, April 12, 2023 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific... | April 12, 2023

Collaboration with the laboratory of Dr. Michael Dustin elucidates the mechanism of action of Immuno-STATs in activating disease-specific T cells by mimicking the natural formation of immune synapses ... | February 16, 2023

Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences - November 22, 2022 - read this article along with other careers information, tips and advice on BioSpace

WuXi will provide Coherent Biopharma with integrated CMC services to accelerate its present and future drug candidates (small molecule, peptide, oligonucleotide, and complex chemical conjugate, etc.), from API to drug product. This will include but not be limited to process development, manufacturing, analytical, and regulatory filing support. Peptide drug conjugates will be a focus of the partnership.

WuXi will provide Coherent Biopharma with integrated CMC services to accelerate its present and future drug candidates (small molecule, peptide, oligonucleotide, and complex chemical conjugate, etc.), from API to drug product. This will include but not be limited to process development, manufacturing, analytical, and regulatory filing support. Peptide drug conjugates will be a focus of the partnership.

/PRNewswire/ -- Armed with a novel strategy they developed for bolstering the bodys immune response, scientists at Albert Einstein College of Medicine have...

/PRNewswire/ -- Armed with a novel strategy they developed for bolstering the bodys immune response, scientists at Albert Einstein College of Medicine have...